XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
OPERATING ACTIVITIES:            
Net loss $ (14,483) $ 13,224   $ (26,079) $ (28,024)  
Adjustments to reconcile net loss to net cash used in operating activities:            
Provision for bad debt     $ 6,300 590 6,263 $ 4,532
DEPRECIATION AND AMORTIZATION 10,905 9,784   21,674 17,344  
Amortization of right-of-use asset       4,025    
Stock-based compensation expense 2,417 1,140   4,222 2,290  
Fair value changes in embedded derivatives       1,120 7,781  
FAIR VALUE CHANGES IN BUSINESS ACQUISITIONS CONTINGENT CONSIDERATION 12,971 3,983   24,035 3,983  
Deferred income taxes       (254) (4,911)  
Other       (87) 983  
Debt extinguishment costs       4,052    
Changes in operating assets and liabilities—net of acquisitions:            
Accounts receivable and contract assets       (31,009) 7,427  
Prepaid expenses and other current assets       1,316 (789)  
Accounts payable and other accrued liabilities       1,788 (8,296)  
Accrued payroll and benefits       (2,846) 1,886  
Payment of contingent consideration and other assumed purchase price obligations       (15,549) (6,175)  
Other assets       (107) (1,346)  
Change in operating leases       (3,937)    
Net cash used in operating activities       (17,046) (1,584)  
INVESTING ACTIVITIES:            
Purchases of property and equipment       (2,354) (3,160)  
Proprietary software development and other software costs       (208) (155)  
Purchase price true ups       (8,377)    
Proceeds from net working capital adjustment related to acquisitions         2,819  
Cash paid for acquisitions—net of cash acquired       (14,876) (173,473)  
Net cash used in investing activities       (25,815) (173,969)  
FINANCING ACTIVITIES:            
Proceeds from line of credit       105,000 104,390  
Payments on line of credit       (40,000) (176,980)  
Proceeds from term loans       175,000 175,000  
Repayment of term loan       (173,905) (48,750)  
Payment of contingent consideration and other purchase price obligations       (9,605) (6,005)  
Repayment of finance leases       (1,143) (1,249)  
Payments of deferred offering costs         (1,462)  
Prepayment premium on credit facility         (351)  
Debt issuance costs       (2,590) (4,866)  
Proceeds from issuance of common stock for exercised stock options       3,086 21  
Issuance of convertible and redeemable Series A-2 preferred stock and warrant         173,664  
Dividend payment to the Series A-2 shareholders       (8,200)    
Net cash provided by financing activities       47,643 213,412  
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH       4,782 37,859  
Foreign exchange impact on cash balance       526 71  
Beginning of year     $ 6,884 34,881 6,884 6,884
End of period $ 40,189 $ 44,814   40,189 44,814 $ 34,881
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:            
Cash paid for interest       3,397 6,539  
Cash paid for income tax       305 72  
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:            
Accrued purchases of property and equipment       907 814  
Property and equipment purchased under finance leases       1,766 1,704  
Accretion of the redeemable series A-1 preferred stock to redeemable value         11,059  
Common stock issued to acquire new businesses       2,746 25,000  
Acquisitions unpaid contingent consideration       31,152 44,994  
Offering costs included in accounts payable and other accrued liabilities         $ 941  
Acquisitions contingent consideration paid in shares       $ 25,000